SCHEMBL5322207

SCHEMBL5322207

CCOC(=O)Cc1cc(-c2ccccc2)n(CC)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.51
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 1/20 0.49
TSHR P16473 1/20 0.49
POLB P06746 3/20 0.48
CYP1A2 P05177 1/20 0.48
THRB P10828 1/20 0.48
CYP2C9 P11712 1/20 0.48
ALOX15 P16050 1/20 0.48
FPR1 P21462 1/20 0.48
CYP2C19 P33261 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HTT P42858 1/20 0.48
TRPM8 Q7Z2W7 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5328276 0.90 ALDH1A1 (0.49) RECQLALDH1A1KDM4EHPGDTSHR
SCHEMBL5966771 0.87 SMPD1 (0.52) RECQLALDH1A1KDM4EHPGDTSHR
SCHEMBL5966736 0.87 NR1H2 (0.51) RECQLALDH1A1KDM4EHPGDTSHR
SCHEMBL5966699 0.86 KDM4E (0.49) RECQLALDH1A1KDM4EHPGDTSHR
SCHEMBL5967128 0.86 SMPD1 (0.57) RECQLALDH1A1KDM4EHPGDTSHR
SCHEMBL5414207 0.86 ALDH1A1 (0.45) RECQLALDH1A1KDM4EHPGDTSHR
SCHEMBL14288144 0.80 FAAH (0.58) ALDH1A1HPGDTSHRPOLBTDP1
SCHEMBL5283603 0.77 HTT (0.60) RECQLALDH1A1KDM4EHPGDTSHR
SCHEMBL7383595 0.75 ALDH1A1 (0.40) RECQLALDH1A1KDM4EHPGDTSHR
SCHEMBL16154000 0.75 TSHR (0.64) RECQLALDH1A1KDM4ETSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 RECQL 2727/4885ALDH1A1 2972/4885KDM4E 4305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.